MedPath

Effect of Mecobalamin on functional outcome of the complex regional pain syndrome type I of foot and ankle , Randomized double blinded controlled trial

Phase 4
Conditions
patient was diagnosed complex regional pain syndrome type I of foot and ankle 18-70 year old.
CRPS type I in foot and ankle .
Registration Number
TCTR20220221002
Lead Sponsor
faculty of medicine Thammasat university foundation 1/2564
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
46
Inclusion Criteria

1.acute CRPS type I in foot and ankle <symptoms less than 3 month>
2. aged 18-70 year old
3. volunteer , fully conscious ,well to cooperate questionnaire

Exclusion Criteria

1. allergy to Mecobalamin and pregabalin
2. Neuropathy condition such as DM with target organ damage, leprosy, Celebrovascular disease .
3.Pregnancy.
4. current use of vitamin B component drug .

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
functional outcome pre-treatment,1month,3month,6month,12month 1. Short Form Health Survey (SF-36) (Thai version) 2. Foot and Ankle Ability Measure (FAAM) score (Thai version)
Secondary Outcome Measures
NameTimeMethod
Visual analog scale,Dosage and duration of Pregabalin used pre-treatment,1month,3month,6month,12month Visual analog scale,Dosage and duration of Pregabalin used
© Copyright 2025. All Rights Reserved by MedPath